The coding sequence for ttsA was amplified from S. Typhi strain ISP2825 and cloned by Gibson cloning strategy 49 (link) into the expression vector pET28a+ (Novagen) resulting in N-terminal his-epitope tagged TtsA. Expression and purification of TtsAWT and catalytic mutant TtsAE14A were carried out as previously described 11 (link). Escherichia coli strain BL21 carrying the different plasmids were grown in LB containing kanamycin (50 μg/ml) to an OD600 nm of 0.6–0.7 at 37°C. Expression of TtsA was subsequently induced by the addition of 0.5 mM IPTG, and induced cultures were incubated overnight at 25°C. Bacterial cells were pelleted by centrifugation, resuspended in lysis buffer [Tris-HCl (150 mM, pH 8.0), NaCl (100 mM), imidazol (10 mM), lysozyme (100 μg/ml), DNAse (100 μg/ml), saturated PMSF] and lysed with a French press. Lysates were subsequently pelleted (20,000g 1h, 4°C), and affinity-purified using a Nickel-resin (Qiagen) column. The eluates were diluted in 20 mM Tris-HCl, pH 8.0 buffer and loaded onto a Hi Trap Q ion-exchange column. Fractions from the ion-exchange chromatography were monitored on SDS–PAGE, concentrated, and further purified by using a Superdex 200 column. Final fractions were examined for purity on a 12 % SDS–PAGE.